Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07523217) titled 'Poly-L-Lactic Acid in Atrophic Acne Scars' on April 3.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).

Primary Sponsor: Zagazig University

Condition: Atrophic Acne Scarring

Intervention: Drug: injectable PLLA

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: March 15, 2024

Target Sample Size: 52

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07523217

Published by HT Digital Content Services with permiss...